治療性 mRNA 的專利追蹤

服務的主要特點

每個季度我們都會為您提供最新的Excel數據庫，包括：

• 新專利申請
• 新授予的專利
• 過期或放棄的專利
• 知識產權轉讓（再轉讓、許可）、知識產權聯合研究
• 專利訴訟/異議
• 按技術類別、應用和治療領域分類的專利：mRNA 設計、遞送、製造、基於 mRNA 的疫苗、基於 mRNA 的療法、傳染病、腫瘤疾病和其他疾病
• 更新在線數據庫的超鏈接（法律狀態、文檔等）

每個季度我們都會提供一份 PDF 報告，其中包含：

• 主要季度業績和數據
• 涵蓋專利格局變化的圖表和評論
• 主要知識產權公司和新進入者

IP Analyst Access（每年 100 小時）：

• 與知識產權分析師就 mRNA 治療領域的趨勢、分析、特定專利技術和公司知識產權組合進行問答會議和討論

釋放 mRNA 療法的優勢：季度專利跟蹤服務

針對 COVID-19 大流行的 mRNA 疫苗的成功凸顯了基於 mRNA 的治療技術的破壞性方面。 COVID-19 是 mRNA 技術平台的眾多適應症之一，對廣泛的微生物病原體和癌症的新疫苗具有很高的前景。 此外，治療性 mRNA 的開發不僅用於疫苗接種，還用於治療罕見和常見疾病，如遺傳、纖維化和自身免疫性疾病。 然而，要將 mRNA 確立為一種通用的治療工具，仍然存在一系列挑戰。 為了克服這些挑戰，已經開發了各種新技術，包括優化 mRNA 運輸的方法、具有組織嗜性的載體和 mRNA 積累。 此外，mRNA 疫苗和治療劑的發展路徑在幾個重要方面存在差異，例如 mRNA 免疫原性、組織嗜性、遞送和藥代動力學，因此未來的發展方向可能會因治療應用而異。

了解不同公司在這個瞬息萬變的環境中的知識產權地位和戰略至關重要。 這些知識有助於我們發現商業風險和機遇，確定新的研究領域，並了解我們競爭對手的戰略。

Therapeutic mRNA Patent Tracking Service 利用季度更新的 excel 文件從季度分析報告和與分析師的直接互動中獲益。 excel 文件包含新的專利申請、新獲得的專利、專利到期/放棄、專利轉讓（再轉讓、許可）和專利訴訟/異議。 這些專利按應用和治療領域以及 mRNA 設計（自擴增和環狀 RNA）、載體、製造和儲存過程等技術領域進行分組。 這個方便的 Excel 電子表格具有指向更新的在線數據庫的超鏈接，允許您按多個標准進行搜索，包括優先權日期、專利受讓人、專利法律狀態和特定領域。 我們的季度 PDF 報告詳細介紹了過去三個月的知識產權趨勢，重點介紹了主要的知識產權公司和專利技術。 直接訪問分析師提供按需問答環節，並就治療性 mRNA 領域的季度結果、趨勢、分析、特定專利技術或公司專利組合進行公開討論。

專利跟蹤服務的優勢

了解競爭對手的知識產權活動和未來意圖

通過使用專利跟蹤服務，您可以了解當前競爭對手的專利活動、知識產權動態、收購和許可等專利轉讓、專利訴訟、技術開發、研發戰略等。 此外，有可能在早期發現公司業務領域的新進入者。

了解最新技術趨勢，預測技術趨勢

通過跟蹤最近的專利申請，您可以跟蹤該領域的最新創新。 了解有關專利發明的更多信息並跟蹤技術發展。 新的技術解決方案可以激發和改進您的研發活動。

防止可能損害業務的知識產權註冊

您可以在專有權被授予之前獲得有關專利申請的信息，並及時做出回應，以防止可能對您的業務產生不利影響的知識產權註冊增加。

快速應對侵權行為，降低法律風險

通過監控新頒發的專利，您可以定期評估您的操作自由度以及您的產品或工藝是否不受專利保護以及是否有他人擁有的有效知識。您可以確保製造、銷售是安全的並在不侵犯任何所有權的情況下使用。

利用免費技術降低研發項目的風險

通過跟蹤過期和廢棄的專利，您可以識別已進入公共領域且可以安全開發的發明。

了解當前的知識產權趨勢和競爭對手的知識產權戰略

每個季度，我們都會提供過去三個月的 IP 趨勢，詳細介紹主要 IP 參與者、新進入者和關鍵專利技術。 重點專利申請人及其發明、塊專利、有前途的專利以及新到期或放棄的重點專利被突出顯示。

拜訪知識產權分析師

通過電話或電子郵件直接與分析師互動，通過按需問答環節和討論（每年 100 小時）獲取有關特定專利技術和公司 IP 組合的具體意見。

Key features of the service

Every quarter an up-to-date Excel database including:

• New patent applications

• Patent applications newly granted

• Expired or abandoned patents

• Transfer of IP rights (re-assignment, licensing) and IP collaborations.

• Patent litigations and oppositions

• Patents categorized by technological segmentation, application and therapeutic area: mRNA design, delivery, manufacturing, mRNA-based vaccines, mRNA-based therapeutics, infectious diseases, oncological disorders and other diseases.

• Hyperlinks to updated online database (legal status, documents etc.)

Every quarter a PDF report including:

• Key facts & figures of the quarter

• Graphs and comments covering the patent landscape evolutions

• A close look at the key IP players and newcomers

Access to an IP analyst for 100 hours per year:

• Q&A sessions and discussions with our IP analysts regarding trends, analyses, specific patented technologies, or companies' IP portfolios in the field of mRNA therapeutics.

Unlocking the benefits of mRNA therapeutics: A quarterly patent monitoring service

The success of mRNA vaccines as a response to the COVID-19 pandemic has shone a light on the disruptive aspect of mRNA-based therapeutic technology. COVID-19 is one of many indications for the mRNA technology platform, which holds high promise for new vaccines with a wide spectrum of microbial pathogens and cancers. Moreover, therapeutic mRNA is not limited to vaccination, but has also been developed to treat both rare and common diseases (genetic diseases, fibrotic diseases, autoimmune disorders, etc.). However, a series of challenges remain to be addressed before mRNA can be established as a general therapeutic modality. An array of new technologies is being developed to surmount these challenges, including approaches to optimize mRNA cargos, carriers with inherent tissue tropism, and mRNA storing, for example. The orientation of future development might also depend on the therapeutic application, as the development pathway for mRNA vaccines and therapeutics differs in several important respects, such as mRNA immunogenicity, tissue tropism, delivery, or pharmacokinetics.

In this fast-evolving context, it is crucial to understand the intellectual property position and strategy of the different players. Such knowledge can help detect business risks and opportunities, identify emerging research areas, and understand competitors' strategies.

The mRNA Therapeutics Patent Monitoring Service allows you to take advantage of a quarterly-updated Excel file and benefit from both quarterly analysis reports and direct interaction with our analysts. The Excel file includes new patent applications, new granted patents, patents expired/abandoned, patent transfers (re-assignment, licensing), and patent litigation/opposition. The patents are categorized by technology segments, including mRNA design (self-amplifying and circular RNA), carriers, manufacturing, and storing process, but also by application and therapeutic area. This useful Excel spreadsheet with hyperlinks to updated online database allows for multi-criteria searches, including priority date, patent assignees, legal status of patents, and specific segments. The quarterly PDF reports provide the IP trends over the last three months, with a close look at key IP players and patented technologies. Direct access to our analysts offers you on-demand Q&A sessions and open discussions regarding the quarterly report results, trends, analyses, specific patented technologies, or companies' patent portfolios in the field of Therapeutic mRNA.

Benefits of the patent monitoring service

Keep an eye on your competitors' IP activities and their future intentions.

With the help of the patent monitoring service, you will be aware of your competitors' current patenting activities, their IP dynamics, patent transfers including acquisitions and licenses, patent litigation, technology development, and R&D strategies. You will also be able to detect newcomers early in your business area.

Keep track of the latest technology developments and stay ahead of technology trends.

By taking note of any recent patent filings, you can track the latest innovations in the field. You will get details on claimed inventions and you can follow technology developments. New technical solutions could inspire and improve your R&D activity.

Prevent registration of IP rights that may be harmful to your business.

You will obtain information on patent applications filed even before exclusive rights have been granted, and you can react in time to prevent registration of IP rights that may be harmful to your business.

React quickly to infringements and mitigate legal risks.

Monitoring newly-issued patents allows you to regularly assess your freedom-to-operate, ensuring that your products or processes are not covered by patents and thus can be manufactured, sold, or used safely without infringing valid IP rights owned by others.

Take advantage of free technologies and reduce R&D project risks.

By tracking both expired patents and abandoned patents, you will be able to identify inventions entering the public domain that you can use safely for your development.

Understand the current IP trends and IP strategy of competitors.

On a quarterly basis, the report will provide the IP trends over the last three months, with a close look at key IP players, newcomers, and key patented technologies. Main patent applicants and their inventions, blocking patents, promising patents, and key newly expired or abandoned patents will be highlighted.

Access an IP analyst.

Take advantage of direct interaction with our analysts by phone and/or email and get specific input for specific patented technologies and companies' IP portfolios through on-demand Q&A sessions and discussion (100 hours per year).